[Clinical experiences with percutaneous digitoxin therapy in pregnant women with varicose veins].
It is reported on the clinical recommendations in a cutaneous treatment with "Digitoxinpasta" in varicose veins of pregnant women. The patients' arrangement in groups and the valuation of the result of the treatment was done after clinical aspects. The rate of failures (12%) ranges in tolerable limits. Neither a "Digitoxinbradycardy" or signs of overdosage were found in the electrocardiogram.
D000287:Administration, Topical; D004074:Digitoxin / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009824:Ointments; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D013997:Time Factors; D014648:Varicose Veins / Q000188:drug therapy*
D009824:Ointments; D004074:Digitoxin
Klinische Erfahrungen mit der perkutanen Digitoxintherapie bei Schwangerschaftsvarizen